Erythropoiesis and globin switching in compound Klf1::Bcl11a mutant mice

Blood

Volumn 121, Issue 13, 2013, Pages 2553-2562

  Esteghamat, Fatemehsadat ^a   Gillemans, Nynke ^a   Bilic, Ivan ^b   Van Den Akker, Emile ^c   Cantu, Ileana ^a   Van Gent, Teus ^a   Klingmuller, Ursula ^d   Van Lom, Kirsten ^a   Von Lindern, Marieke ^c   Grosveld, Frank ^a   Van Dijk, Thamar Bryn ^a   Busslinger, Meinrad ^b   Philipsen, Sjaak ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b RESEARCH INSTITUTE OF MOLECULAR PATHOLOGY   (Austria)

^c SANQUIN RESEARCH   (Netherlands)

^d GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

GLOBIN; KRUPPEL LIKE FACTOR; KRUPPEL LIKE FACTOR 1; PROTEIN BCL 11A; PROTEIN BCL 2; UNCLASSIFIED DRUG; BCL11A PROTEIN, MOUSE; CARRIER PROTEIN; ERYTHROID KRUPPEL LIKE FACTOR; ERYTHROID KRUPPEL-LIKE FACTOR; NUCLEAR PROTEIN;

ALLELE; ANEMIA; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ERYTHROPOIESIS; FETUS DEVELOPMENT; GENE LOCUS; IN VIVO STUDY; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RETICULOCYTE; RETICULOCYTOSIS; TRANSGENE; ANIMAL; ANIMAL EMBRYO; CYTOLOGY; GENE EXPRESSION REGULATION; GENE REARRANGEMENT; GENETICS; HUMAN; METABOLISM; MOUSE MUTANT; PHYSIOLOGY; PRENATAL DEVELOPMENT; REGULATOR GENE; SPLEEN; TRANSGENIC MOUSE;

ANIMALS; CARRIER PROTEINS; EMBRYO, MAMMALIAN; ERYTHROPOIESIS; FETAL DEVELOPMENT; GENE EXPRESSION REGULATION, DEVELOPMENTAL; GENE REARRANGEMENT; GENES, SWITCH; GLOBINS; HUMANS; KRUPPEL-LIKE TRANSCRIPTION FACTORS; MICE; MICE, MUTANT STRAINS; MICE, TRANSGENIC; NUCLEAR PROTEINS; RETICULOCYTOSIS; SPLEEN;

MLCS; MLOWN;

EID: 84878383486     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2012-06-434530     Document Type: Article

References (50)

1. Angastiniotis M, Modell B. Global epidemiology of hemoglobin disorders. Ann N Y Acad Sci. 1998; 850:251-269.
2. Stamatoyannopoulos G, Grosveld F. In: Stamatoyannopoulos G, Majerus PW, Perlmutter RM, Varmus H, eds. Hemoglobin switching. In: The Molecular Basis of Blood Diseases. 3rd Ed. Philadelphia, PA: WB Saunders Company; 2001:135-182.
3. Gambari R. Foetal haemoglobin inducers and thalassaemia: novel achievements. Blood Transfus. 2010;8(1):5-7.
4. Steinberg MH. Therapies to increase fetal hemoglobin in sickle cell disease. Curr Hematol Rep. 2003;2(2):95-101.
5. Higgs DR, Gibbons RJ. The molecular basis of a-thalassemia: A model for understanding human molecular genetics. Hematol Oncol Clin North Am. 2010;24(6): 1033-1054.
6. Palis J. Ontogeny of erythropoiesis. Curr Opin Hematol. 2008;15(3):155-161.
7. de Krom M, van de Corput M, von Lindern M, et al. Stochastic patterns in globin gene expression are established prior to transcriptional activation and are clonally inherited. Mol Cell. 2002;9(6): 1319-1326.
8. Sankaran VG, Xu J, Ragoczy T, et al. Developmental and species-divergent globin switching are driven by BCL11A. Nature. 2009; 460(7259):1093-1097.
9. Menzel S, Garner C, Gut I, et al. A QTL influencing F cell production maps to a gene encoding a zinc-finger protein on chromosome 2p15. Nat Genet. 2007;39(10):1197-1199.
10. Uda M, Galanello R, Sanna S, et al. Genomewide association study shows BCL11A associated with persistent fetal hemoglobin and amelioration of the phenotype of beta-thalassemia. Proc Natl Acad Sci USA. 2008;105(5):1620-1625.
11. Sankaran VG, Menne TF, Xu J, et al. Human fetal hemoglobin expression is regulated by the developmental stage-specific repressor BCL11A. Science. 2008;322(5909):1839-1842.
12. Siatecka M, Bieker JJ. The multifunctional role of EKLF/KLF1 during erythropoiesis. Blood. 2011; 118(8):2044-2054.
13. Borg J, Papadopoulos P, Georgitsi M, et al. Haploinsufficiency for the erythroid transcription factor KLF1 causes hereditary persistence of fetal hemoglobin. Nat Genet. 2010;42(9):801-805.
14. Zhou D, Liu K, Sun CW, et al. KLF1 regulates BCL11A expression and gamma- to beta-globin gene switching. Nat Genet. 2010;42(9):742-744.
15. Donze D, Townes TM, Bieker JJ. Role of erythroid Kruppel-like factor in human gamma- to betaglobin gene switching. J Biol Chem. 1995;270(4): 1955-1959.
16. Nuez B, Michalovich D, Bygrave A, et al. Defective haematopoiesis in fetal liver resulting from inactivation of the EKLF gene. Nature. 1995; 375(6529):316-318.
17. Perkins AC, Sharpe AH, Orkin SH. Lethal betathalassaemia in mice lacking the erythroid CACCC-transcription factor EKLF. Nature. 1995; 375(6529):318-322.
18. Perkins AC, Gaensler KM, Orkin SH. Silencing of human fetal globin expression is impaired in the absence of the adult beta-globin gene activator protein EKLF. Proc Natl Acad Sci USA. 1996; 93(22):12267-12271.
19. Wijgerde M, Gribnau J, Trimborn T, et al. The role of EKLF in human beta-globin gene competition. Genes Dev. 1996;10(22):2894-2902.
20. Singleton BK, Burton NM, Green C, et al. Mutations in EKLF/KLF1 form the molecular basis of the rare blood group In(Lu) phenotype. Blood. 2008;112(5):2081-2088.
21. Satta S, Perseu L, Moi P, et al. Compound heterozygosity for KLF1 mutations associated with remarkable increase of fetal hemoglobin and red cell protoporphyrin. Haematologica. 2011; 96(5):767-770.
22. Perseu L, Satta S, Moi P, et al. KLF1 gene mutations cause borderline HbA(2). Blood. 2011; 118(16):4454-4458.
23. Arnaud L, Saison C, Helias V, et al. A dominant mutation in the gene encoding the erythroid transcription factor KLF1 causes a congenital dyserythropoietic anemia. Am J Hum Genet. 2010;87(5):721-727.
24. Heinrich AC, Pelanda R, Klingmüller U. A mouse model for visualization and conditional mutations in the erythroid lineage. Blood. 2004;104(3): 659-666.
25. Beug H, Palmieri S, Freudenstein C, et al. Hormone-dependent terminal differentiation in vitro of chicken erythroleukemia cells transformed by ts mutants of avian erythroblastosis virus. Cell. 1982;28(4):907-919.
26. Esteghamat F, van Dijk TB, Braun H, et al. The DNA binding factor Hmg20b is a repressor of erythroid differentiation. Haematologica. 2011; 96(9):1252-1260.
27. van Dijk TB, Gillemans N, Pourfarzad F, et al. Fetal globin expression is regulated by Friend of Prmt1. Blood. 2010;116(20):4349-4352.
28. Xu J, Peng C, Sankaran VG, et al. Correction of sickle cell disease in adult mice by interference with fetal hemoglobin silencing. Science. 2011; 334(6058):993-996.
29. Liu P, Keller JR, Ortiz M, et al. Bcl11a is essential for normal lymphoid development. Nat Immunol. 2003;4(6):525-532.
30. Piva E, Brugnara C, Chiandetti L, et al. Automated reticulocyte counting: State of the art and clinical applications in the evaluation of erythropoiesis. Clin Chem Lab Med. 2010;48(10):1369-1380.
31. Ponka P, Lok CN. The transferrin receptor: Role in health and disease. Int J Biochem Cell Biol. 1999; 31(10):1111-1137.
32. Antonchuk J, Hyland CD, Hilton DJ, et al. Synergistic effects on erythropoiesis, thrombopoiesis, and stem cell competitiveness in mice deficient in thrombopoietin and steel factor receptors. Blood. 2004;104(5):1306-1313.
33. Socolovsky M. Molecular insights into stress erythropoiesis. Curr Opin Hematol. 2007;14(3): 215-224.
34. Drissen R, von Lindern M, Kolbus A, et al. The erythroid phenotype of EKLF-null mice: Defects in hemoglobin metabolism and membrane stability. Mol Cell Biol. 2005;25(12):5205-5214.
35. Hodge D, Coghill E, Keys J, et al. A global role for EKLF in definitive and primitive erythropoiesis. Blood. 2006;107(8):3359-3370.
36. Pilon AM, Arcasoy MO, Dressman HK, et al. Failure of terminal erythroid differentiation in EKLF-deficient mice is associated with cell cycle perturbation and reduced expression of E2F2. Mol Cell Biol. 2008;28(24):7394-7401.
37. Perkins AC, Peterson KR, Stamatoyannopoulos G, et al. Fetal expression of a human Agamma globin transgene rescues globin chain imbalance but not hemolysis in EKLF null mouse embryos. Blood. 2000;95(5):1827-1833.
38. Borg J, Patrinos GP, Felice AE, et al. Erythroid phenotypes associated with KLF1 mutations. Haematologica. 2011;96(5):635-638.
39. Heruth DP, Hawkins T, Logsdon DP, et al. Mutation in erythroid specific transcription factor KLF1 causes Hereditary Spherocytosis in the Nan hemolytic anemia mouse model. Genomics. 2010; 96(5):303-307.
40. Siatecka M, Sahr KE, Andersen SG, et al. Severe anemia in the Nan mutant mouse caused by sequence-selective disruption of erythroid Kruppel-like factor. Proc Natl Acad Sci USA. 2010;107(34):15151-15156.
41. Strouboulis J, Dillon N, Grosveld F. Developmental regulation of a complete 70-kb human beta-globin locus in transgenic mice. Genes Dev. 1992;6(10):1857-1864.
42. Garrick D, De Gobbi M, Samara V, et al. The role of the polycomb complex in silencing alpha-globin gene expression in nonerythroid cells. Blood. 2008;112(9):3889-3899.
43. Ganesh SK, Zakai NA, van Rooij FJ, et al. Multiple loci influence erythrocyte phenotypes in the CHARGE Consortium. Nat Genet. 2009;41(11): 1191-1198.
44. Buller AM, Elford HL, DuBois CC, et al. A combination of hydroxyurea and isobutyramide to induce fetal hemoglobin in transgenic mice is more hematotoxic than the individual agents. Blood Cells Mol Dis. 1999;25(3-4):255-269.
45. Pace B, Li Q, Peterson K, et al. alpha-Amino butyric acid cannot reactivate the silenced gamma gene of the beta locus YAC transgenic mouse. Blood. 1994;84(12):4344-4353.
46. Thein SL, Menzel S, Peng X, et al. Intergenic variants of HBS1L-MYB are responsible for a major quantitative trait locus on chromosome 6q23 influencing fetal hemoglobin levels in adults. Proc Natl Acad Sci USA. 2007;104(27): 11346-11351.
47. Xu J, Sankaran VG, Ni M, et al. Transcriptional silencing of gamma-globin by BCL11A involves long-range interactions and cooperation with SOX6. Genes Dev. 2010;24(8):783-798.
48. Gnanapragasam MN, Scarsdale JN, Amaya ML, et al. p66Alpha-MBD2 coiled-coil interaction and recruitment of Mi-2 are critical for globin gene silencing by the MBD2-NuRD complex. Proc Natl Acad Sci USA. 2011;108(18):7487-7492.
49. Cui S, Kolodziej KE, Obara N, et al. Nuclear receptors TR2 and TR4 recruit multiple epigenetic transcriptional corepressors that associate specifically with the embryonic b-type globin promoters in differentiated adult erythroid cells. Mol Cell Biol. 2011;31(16):3298-3311.
50. Rank G, Cerruti L, Simpson RJ, et al. Identification of a PRMT5-dependent repressor complex linked to silencing of human fetal globin gene expression. Blood. 2010;116(9):1585-1592